Intercept Pharmaceuticals Competitors and Similar CompaniesClear all
Intercept Pharmaceuticals's competitors and similar companies include Promethera Biosciences and CSL Behring.
 Intercept Pharmaceuticals Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases. |  Promethera Biosciences Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases. | ||
Founding Date | Founding Date 2002 | Founding Date 2009 | Founding Date 1904 |
Type | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||
Locations | Locations New York, US HQ Wien, AT Mississauga, CA Kongens Lyngby, DK Paris, FR München, DE Dublin, IE see more | Locations Mont-Saint-Guibert, BE HQ Charleroi, BE Ganshoren, BE Chuo City, JP Chuo City, JP Basel, CH Durham, US see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 58321% increase | Employees 185% decrease | Employees 7,5692% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $285.7m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $7.9b (FY, 2020) |
Gross profit | Gross profit $284.7m (FY, 2022) | Gross profit N/A | Gross profit $4.5b (FY, 2020) |
Funding | |||
Total funding raised | Total funding raised $ 55m | Total funding raised $ 146m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Promethera Biosciences
HQ
Mont-Saint-Guibert, BE
Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases.
View company